German investor Paragon Partners buys Balda AG for Euro 62.9 mn

 
Paragon Partners is aiming to sustainably improve the strategic and operating business of its shareholdings. Paragons founding partner Krischan von Moeller added, “Under the successful management team, the Balda Group will continue as an operational unit in accordance with today's strategic orientation. We will support Balda to actively make use of growth opportunities in the areas of medical technology as well as pharmaceutical and, if needed, may provide further equity for organic and external growth."
 
Oliver Oechsle said, "By selling the operating business of the Balda Group, we are creating a significant increase in value for the shareholders. Paragon Partners has confirmed that it will maintain the current strategic orientation and organisational structure and that it will retain all employees of Balda AG as well as the management. This means stability and continuity. Balda pursues the goal of continuing to further develop over the next few years - both organically and strategically so as to achieve an order of magnitude that will offer us completely new courses of action."